abstract |
Novel compounds of formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof useful in the treatment of diseases and disorders mediated by RORγ are provided. Also provided are pharmaceutical compositions comprising the novel compounds of formula (I), and methods for their use in the treatment of one or more inflammatory, metabolic, autoimmune and other diseases or disorders. |